<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64815</article-id><article-id pub-id-type="doi">10.7554/eLife.64815</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>The Development of <italic>Nanosota-1</italic> as anti-SARS-CoV-2 nanobody drug candidates</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-215096"><name><surname>Ye</surname><given-names>Gang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6034-2174</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-215105"><name><surname>Gallant</surname><given-names>Joseph</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4943-1744</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-215108"><name><surname>Zheng</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215106"><name><surname>Massey</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215107"><name><surname>Shi</surname><given-names>Ke</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-116955"><name><surname>Tai</surname><given-names>Wanbo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9864-8993</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215109"><name><surname>Odle</surname><given-names>Abby</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215110"><name><surname>Vickers</surname><given-names>Molly</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215111"><name><surname>Shang</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-215112"><name><surname>Wan</surname><given-names>Yushun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-117154"><name><surname>Du</surname><given-names>Lanying</given-names><suffix>Dr.</suffix></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-114596"><name><surname>Aihara</surname><given-names>Hideki</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7508-6230</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-154478"><name><surname>Perlman</surname><given-names>Stanley</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-215117"><name><surname>LeBeau</surname><given-names>Aaron</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" corresp="yes" id="author-154155"><name><surname>Li</surname><given-names>Fang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1958-366X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf7"/></contrib><aff id="aff1"><institution content-type="dept">Veterinary and Biomedical Sciences</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Saint Paul</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Pharmacology</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Microbiology and Immunology</institution>, <institution>University of Iowa</institution>, <addr-line><named-content content-type="city">Iowa City</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Institutional Office of Regulated Nonclinical Studies</institution>, <institution>University of Texas Medical Branch</institution>, <addr-line><named-content content-type="city">Galveston,</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Biochemistry, Molecular Biology and Biophysics</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">New York Blood Center</institution>, <institution>Lindsley F Kimball Research Institute</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Viral Immunology Laboratory</institution>, <institution>Lindsley F Kimball Research Institute, New York Blood Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-62461"><name><surname>Schoggins</surname><given-names>John W</given-names></name><role>Reviewing editor</role><aff><institution>University of Texas Southwestern Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>alebeau@umn.edu</email> (AL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>lifang@umn.edu</email> (FL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>08</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64815</elocation-id><history><date date-type="received"><day>11</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Ye et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ye et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64815-v1.pdf"/><abstract><p>Combating the COVID-19 pandemic requires potent and low-cost therapeutics. We identified a series of single-domain antibodies (i.e., nanobody), <italic>Nanosota-1</italic>, from a camelid nanobody phage display library. Structural data showed that <italic>Nanosota-1</italic> bound to the oft-hidden receptor-binding domain (RBD) of SARS-CoV-2 spike protein, blocking viral receptor ACE2. The lead drug candidate possessing an Fc tag (<italic>Nanosota-1C-Fc</italic>) bound to SARS-CoV-2 RBD ~3000 times more tightly than ACE2 did and inhibited SARS-CoV-2 pseudovirus ~160 times more efficiently than ACE2 did. Administered at a single dose, <italic>Nanosota-1C-Fc</italic> demonstrated preventive and therapeutic efficacy against live SARS-CoV-2 infection in both hamster and mouse models. Unlike conventional antibodies, <italic>Nanosota-1C-Fc</italic> was produced at high yields in bacteria and had exceptional thermostability. Pharmacokinetic analysis of <italic>Nanosota-1C-F</italic>c documented an excellent <italic>in vivo</italic> stability and a high tissue bioavailability. As effective and inexpensive drug candidates, <italic>Nanosota-1</italic> may contribute to the battle against COVID-19.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI157975</award-id><principal-award-recipient><name><surname>Du</surname><given-names>Lanying</given-names><suffix>Dr.</suffix></name><name><surname>Perlman</surname><given-names>Stanley</given-names></name><name><surname>LeBeau</surname><given-names>Aaron</given-names></name><name><surname>Li</surname><given-names>Fang</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI089728</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Fang</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM118047</award-id><principal-award-recipient><name><surname>Aihara</surname><given-names>Hideki</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007249</institution-id><institution>University of Minnesota</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Li</surname><given-names>Fang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Gang Ye, The University of Minnesota has filed a patent on Nanosota-1 drugs with F.L, G.Y., A.M.L., J.P.G., J.S., and Y.W. as inventors..</p></fn><fn fn-type="conflict" id="conf3"><p>Joseph Gallant, The University of Minnesota has filed a patent on Nanosota-1 drugs with F.L, G.Y., A.M.L., J.P.G., J.S., and Y.W. as inventors..</p></fn><fn fn-type="conflict" id="conf4"><p>Jian Shang, The University of Minnesota has filed a patent on Nanosota-1 drugs with F.L, G.Y., A.M.L., J.P.G., J.S., and Y.W. as inventors..</p></fn><fn fn-type="conflict" id="conf5"><p>Yushun Wan, The University of Minnesota has filed a patent on Nanosota-1 drugs with F.L, G.Y., A.M.L., J.P.G., J.S., and Y.W. as inventors..</p></fn><fn fn-type="conflict" id="conf6"><p>Aaron LeBeau, The University of Minnesota has filed a patent on Nanosota-1 drugs with F.L, G.Y., A.M.L., J.P.G., J.S., and Y.W. as inventors..</p></fn><fn fn-type="conflict" id="conf7"><p>Fang Li, The University of Minnesota has filed a patent on Nanosota-1 drugs with F.L, G.Y., A.M.L., J.P.G., J.S., and Y.W. as inventors..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the University of Texas Medical Branch (protocol number 2007072), of the New York Blood Center (protocol number 194.22), of the University of Iowa (protocol number 9051795), and of the University of Minnesota (protocol number 2009-38426A).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Coordinates and structure factors have been deposited to the Protein Data Bank with accession number 7KM5.</p></sec><supplementary-material><ext-link xlink:href="elife-64815-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>